Development of antagonists that disrupt the hyperactivated camp signalling pathway in immunodeficiencies as immunostimulatory therapy (NEW CAMP ANTAGONISTS)
Desde 2002-12-01
hasta 2005-01-31
Detalles del proyecto
Coste total:
EUR 1 901 224Aportación de la UE:
EUR 945 844Coordinado en:
NorwayRégimen de financiación:
CRS - Cooperative research contractsCoordinador
LAURAS AS
Norway
Participantes
BIAFFIN GMBH & CO KG
Germany
BIOLOG LIFE SCIENCE INSTITUTE, FORSCHUNGSLABOR UND BIOCHEMICA- VERTRIEB GMBH
Germany
UNIVERSITE DE LIEGE
Belgium
UNIVERSITY OF KASSEL
Germany
Heinrich Piett Strasse, 40, Raum 2161
34132 KASSEL
Germany
34132 KASSEL
Germany
Contacto administrativo: Manfred NETTEKOVEN
Fax: +38-61-2804484
Fax: +38-61-2804484
UNIVERSITY OF OSLO
Norway
